{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:28:22Z","timestamp":1788352102014,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100015027","name":"Vice Chancellor for Research and Technology, Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["140105113508"],"award-info":[{"award-number":["140105113508"]}],"id":[{"id":"10.13039\/501100015027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.humimm.2023.01.002","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T15:17:27Z","timestamp":1673363847000},"page":"235-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Enhanced production of interleukin-29 and related genes are associated with T helper 1 cell parameters in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4618-352X","authenticated-orcid":false,"given":"Zahra","family":"Sardarmelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8469-5182","authenticated-orcid":false,"given":"Vida","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghasem","family":"Solgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8940-3847","authenticated-orcid":false,"given":"Mahdi","family":"Behzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2023.01.002_b0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.humimm.2023.01.002_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152113","article-title":"Reduced frequency and functional potency of CD49d(-) T regulatory cells in patients with newly diagnosed type 2 diabetes mellitus","volume":"226","author":"Borzouei","year":"2021","journal-title":"Immunobiology."},{"key":"10.1016\/j.humimm.2023.01.002_b0015","doi-asserted-by":"crossref","first-page":"7457269","DOI":"10.1155\/2018\/7457269","article-title":"Role of Adaptive and Innate Immunity in Type 2 Diabetes Mellitus","volume":"2018","author":"Zhou","year":"2018","journal-title":"J Diabetes Res."},{"key":"10.1016\/j.humimm.2023.01.002_b0020","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41423-019-0220-6","article-title":"Helper T cell differentiation","volume":"16","author":"Saravia","year":"2019","journal-title":"Cell Mol Immunol."},{"key":"10.1016\/j.humimm.2023.01.002_b0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine."},{"key":"10.1016\/j.humimm.2023.01.002_b0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nri2958","article-title":"Genomic views of STAT function in CD4+ T helper cell differentiation","volume":"11","author":"O'Shea","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.humimm.2023.01.002_b0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/eci.12.22","article-title":"Stability of T-cell lineages in autoimmune diseases","volume":"8","author":"Raphael","year":"2012","journal-title":"Expert Rev Clin Immunol."},{"key":"10.1016\/j.humimm.2023.01.002_b0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00109-011-0816-5","article-title":"The imbalance of Th17\/Th1\/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications","volume":"90","author":"Zeng","year":"2012","journal-title":"J Mol Med (Berl)."},{"key":"10.1016\/j.humimm.2023.01.002_b0045","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fimmu.2020.01582","article-title":"The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System","volume":"11","author":"Daryabor","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.humimm.2023.01.002_b0050","doi-asserted-by":"crossref","first-page":"204ra129","DOI":"10.1126\/scitranslmed.3006245","article-title":"IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis","volume":"5","author":"Wolk","year":"2013","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.humimm.2023.01.002_b0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.critrevonc.2016.08.002","article-title":"The role of IL-29 in immunity and cancer","volume":"106","author":"Kelm","year":"2016","journal-title":"Crit Rev Oncol Hematol."},{"key":"10.1016\/j.humimm.2023.01.002_b0060","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/gene.2009.72","article-title":"Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines","volume":"10","author":"Witte","year":"2009","journal-title":"Genes Immun."},{"key":"10.1016\/j.humimm.2023.01.002_b0065","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1111\/jcmm.14697","article-title":"Insights into IL-29: Emerging role in inflammatory autoimmune diseases","volume":"23","author":"Wang","year":"2019","journal-title":"J Cell Mol Med."},{"key":"10.1016\/j.humimm.2023.01.002_b0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.gene.6364348","article-title":"Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1\/IL-29)","volume":"8","author":"Jordan","year":"2007","journal-title":"Genes Immun."},{"key":"10.1016\/j.humimm.2023.01.002_b0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1620\/tjem.241.89","article-title":"Elevated Serum Levels of Interleukin-29 Are Associated with Disease Activity in Rheumatoid Arthritis Patients with Anti-Cyclic Citrullinated Peptide Antibodies","volume":"241","author":"Chang","year":"2017","journal-title":"Tohoku J Exp Med."},{"key":"10.1016\/j.humimm.2023.01.002_b0080","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.abd.2020.11.007","article-title":"Enhanced serum interferon-lambda 1 interleukin-29 levels in patients with psoriasis vulgaris","volume":"96","author":"Fu","year":"2021","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.humimm.2023.01.002_b0085","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/08820139.2016.1208215","article-title":"Increased Serum Levels of IL-28 and IL-29 and the Protective Effect of IL28B rs8099917 Polymorphism in Patients with Hashimoto's Thyroiditis","volume":"45","author":"Arpaci","year":"2016","journal-title":"Immunol Invest."},{"key":"10.1016\/j.humimm.2023.01.002_b0090","doi-asserted-by":"crossref","first-page":"9631510","DOI":"10.1155\/2016\/9631510","article-title":"Interleukin-29 Enhances Synovial Inflammation and Cartilage Degradation in Osteoarthritis","volume":"2016","author":"Xu","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.humimm.2023.01.002_b0095","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00011-019-01265-5","article-title":"The increased T helper cells proliferation and inflammatory responses in patients with type 2 diabetes mellitus is suppressed by sitagliptin and vitamin D3 in vitro","volume":"68","author":"Mahabadi-Ashtiyani","year":"2019","journal-title":"Inflamm Res."},{"key":"10.1016\/j.humimm.2023.01.002_b0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/jir.2018.0144","article-title":"Anti-Inflammatory Effect of Combined Sitagliptin and Vitamin D3 on Cytokines Profile in Patients with Type 2 Diabetes Mellitus","volume":"39","author":"Borzouei","year":"2019","journal-title":"J Interferon Cytokine Res."},{"key":"10.1016\/j.humimm.2023.01.002_b0105","doi-asserted-by":"crossref","unstructured":"L.F. da Rocha Junior, A.L. Branco Pinto Duarte, M.J.B. de Melo R\u00eago, A.R. de Almeida, K. de Melo Vilar, H.D. de Lima, A. Tavares Dantas, H. de Ata\u00edde Mariz, I. da Rocha Pitta, M.G. da Rocha Pitta, Sensitivity and specificity of Interleukin 29 in patients with rheumatoid arthritis and other rheumatic diseases, Immunol Lett. 220 (2020) 38-43. 10.1016\/j.imlet.2020.01.004.","DOI":"10.1016\/j.imlet.2020.01.004"},{"key":"10.1016\/j.humimm.2023.01.002_b0110","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/cen.14418","article-title":"Evaluation of interleukin-29 in autoimmune and inflammatory thyroid diseases","volume":"94","author":"Falkowski","year":"2021","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.humimm.2023.01.002_b0115","doi-asserted-by":"crossref","unstructured":"M.A.M. Afify, D.M.A. Elzoghby, A.M. Sarhan, R. Eladawy, Levels of Growth Differentiation Factor 15 and Interleukin-29 in Children and Adolescents with Type 1 Diabetes Mellitus, The Egyptian Journal of Hospital Medicine. 89 (2022) 7167-7175. 10.21608\/ejhm.2022.273060.","DOI":"10.21608\/ejhm.2022.273060"},{"key":"10.1016\/j.humimm.2023.01.002_b0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2265.2012.04384.x","article-title":"Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study)","volume":"78","author":"Marques-Vidal","year":"2013","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.humimm.2023.01.002_b0125","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1177\/0300060516672369","article-title":"Th17 cell frequency and IL-17A concentrations in peripheral blood mononuclear cells and vitreous fluid from patients with diabetic retinopathy","volume":"44","author":"Chen","year":"2016","journal-title":"J Int Med Res."},{"key":"10.1016\/j.humimm.2023.01.002_b0130","doi-asserted-by":"crossref","first-page":"17023-","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"Liu","year":"2017","journal-title":"NF-\u03baB signaling in inflammation, Signal Transduct Target Ther."},{"key":"10.1016\/j.humimm.2023.01.002_b0135","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.humimm.2023.01.002_b0140","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/08830185.2015.1087519","article-title":"STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic Potential","volume":"35","author":"Chmielewski","year":"2016","journal-title":"Int Rev Immunol."},{"key":"10.1016\/j.humimm.2023.01.002_b0145","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/jir.2020.0113","article-title":"Evaluation of Interleukin-23 and JAKs\/STATs\/SOCSs\/ROR-\u03b3t Expression in Type 2 Diabetes Mellitus Patients Treated With or Without Sitagliptin","volume":"40","author":"Rezaeepoor","year":"2020","journal-title":"J Interferon Cytokine Res."},{"key":"10.1016\/j.humimm.2023.01.002_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2022.111779","article-title":"Activation of inflammatory pathways in PBMCs linking type 2 diabetes in older adults without obesity","volume":"163","author":"Cheng","year":"2022","journal-title":"Exp Gerontol."},{"key":"10.1016\/j.humimm.2023.01.002_b0155","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/08820139.2019.1586917","article-title":"Analysis of Inflammatory Gene Expression Profile of Peripheral Blood Leukocytes in Type 2 Diabetes","volume":"48","author":"Inayat","year":"2019","journal-title":"Immunol Invest."},{"key":"10.1016\/j.humimm.2023.01.002_b0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fimmu.2020.00195","article-title":"The Role of Calcium-Calcineurin-NFAT Signaling Pathway in Health and Autoimmune Diseases","volume":"11","author":"Park","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.humimm.2023.01.002_b0165","first-page":"1252","article-title":"Activation of the Peroxisome Proliferator-Activated Receptor \u03b3 Coactivator 1\u03b2\/NFATc1 Pathway in Circulating Osteoclast Precursors Associated With Bone Destruction in Rheumatoid Arthritis, Arthritis","volume":"71","author":"Ma","year":"2019","journal-title":"Rheumatol."},{"key":"10.1016\/j.humimm.2023.01.002_b0170","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/ni.2059","article-title":"T-bet in disease","volume":"12","author":"Lazarevic","year":"2011","journal-title":"Nat Immunol."},{"key":"10.1016\/j.humimm.2023.01.002_b0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1155\/2013\/931915","article-title":"Inflammatory cytokines and the risk of cardiovascular complications in type 2 diabetes","volume":"35","author":"Mahmoud","year":"2013","journal-title":"Dis Markers."},{"key":"10.1016\/j.humimm.2023.01.002_b0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/oby.21243","article-title":"Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNF\u03b1 production","volume":"24","author":"Ip","year":"2016","journal-title":"Obesity (Silver Spring)."},{"key":"10.1016\/j.humimm.2023.01.002_b0185","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2567.2008.02862.x","article-title":"Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro","volume":"125","author":"Srinivas","year":"2008","journal-title":"Immunology."},{"key":"10.1016\/j.humimm.2023.01.002_b0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13075-017-1344-7","article-title":"IFN-lambda1 with Th17 axis cytokines and IFN-alpha define different subsets in systemic lupus erythematosus (SLE)","volume":"19","author":"Oke","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.humimm.2023.01.002_b0195","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.gene.6364382","article-title":"Human interferon lambda-1 (IFN-lambda1\/IL-29) modulates the Th1\/Th2 response","volume":"8","author":"Jordan","year":"2007","journal-title":"Genes Immun."},{"key":"10.1016\/j.humimm.2023.01.002_b0200","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.4049\/jimmunol.168.10.4936","article-title":"Sustained NFAT signaling promotes a Th1-like pattern of gene expression in primary murine CD4+ T cells","volume":"168","author":"Porter","year":"2002","journal-title":"J Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:57:09Z","timestamp":1759319829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885923000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0198885923000022"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2023.01.002","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced production of interleukin-29 and related genes are associated with T helper 1 cell parameters in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2023.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}